48
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor

, , , , , , , & show all
Pages 3079-3086 | Published online: 22 Oct 2015

References

  • BosettiCTuratiFLa VecchiaCHepatocellular carcinoma epidemiologyBest Pract Res Clin Gastroenterol201428575377025260306
  • WangZZhangGWuJJiaMAdjuvant therapy for hepatocellular carcinoma: current situation and prospectDrug Discov Ther20137413714324071575
  • CormierJNThomasKTChariRSPinsonCWManagement of hepatocellular carcinomaJ Gastrointest Surg200610576178016713550
  • OsakiYNishikawaHTreatment for hepatocellular carcinoma in Japan over the last three decades: our experience and published work reviewHepatol Res2015451597424965914
  • ChenXLiuHPLiMQiaoLAdvances in non-surgical management of primary liver cancerWorld J Gastroenterol20142044166301663825469032
  • FonsecaALChaCHHepatocellular carcinoma: a comprehensive overview of surgical therapyJ Surg Oncol2014110671271924894746
  • LheureuxSClarisseBLaunay-VacherVEvaluation of current practice: management of chemotherapy-related toxicitiesAnticancer Drugs201122991992521795972
  • ChenMHYangWYanKLarge liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients – mathematic model, overlapping mode, and electrode placement processRadiology2004232126027115166323
  • HuangYJHsuHCWangCYThe treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinomaInt J Radiat Oncol Biol Phys20097341155116318760547
  • MarelliLStiglianoRTriantosCTreatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapiesCancer Treat Rev200632859460617045407
  • KamimuraKSudaTTamuraYPhase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinomaBMC Gastroenterol20121212722994941
  • SaharaSKawaiNSatoMProspective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinomaCardiovasc Intervent Radiol20123561363137122358993
  • OnozukaHTsuchiharaKEsumiHHypoglycemic/hypoxic condition in vitro mimicking the tumor microenvironment markedly reduced the efficacy of anticancer drugsCancer Sci2011102597598221255190
  • GaoYShenJKMilaneLHornicekFJAmijiMMDuanZTargeted cancer therapy: nanotechnology approaches for overcoming drug resistanceCurr Med Chem201522111335134725666804
  • ShaoRGZhenYSEnediyne anticancer antibiotic lidamycin: chemistry, biology and pharmacologyAnticancer Agents Med Chem20088212313118288918
  • ShiYKWuSYHuangYHZhenYSChemosensitivity of mdr1 gene overexpressed multidrug resistant cancer cells to lidamycinYao Xue Xue Bao2006411211461151 Chinese17290610
  • BeermanTAGawronLSShinSShenBMchughMMC-1027, a radiomimetic enediyne anticancer drug, preferentially targets hypoxic cellsCancer Res200969259359819147573
  • ZhongGZhangSLiYA tandem scFv-based fusion protein and its enediyne-energized analogue show intensified therapeutic efficacy against lung carcinoma xenograft in athymic miceCancer Lett2010295112413320303650
  • TangCMYuJHypoxia-inducible factor-1 as a therapeutic target in cancerJ Gastroenterol Hepatol201328340140523173651
  • KeithBJohnsonRSSimonMCHIF1α and HIF2α: sibling rivalry in hypoxic tumor growth and progressionNat Rev Cancer201112192222169972
  • MartinengoCPoggioTMenottiMALK-dependent control of hypoxia inducible factors mediates tumor growth and metastasisCancer Res201474216094610625193384
  • LiaoYLuWCheQSHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1α levelPLoS One201496e9990724918449
  • WarfelNAEI-DeiryWSHIF-1 signaling in drug resistance to chemotherapyCurr Med Chem201421263021302824735366
  • PiresIMBloklandNJBroosAWHIF-1α-independent hypoxia-induced rapid PTK6 stabilization is associated with increased motility and invasionCancer Biol Ther201415101350135725019382
  • WangTGikesDMTakanoNHypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasisProc Natl Acad Sci U S A201411131E3234E324224938788